Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea-hypopnoea syndrome
HbA1c, fructosamine, weight, BMI, total daily insulin dose and continuous glucose monitoring measures were analyzed at baseline before GLP-1 therapy began and 3 and 6 months after GLP-1 initiation
It wasnt easy, and it required a lot of translation of things written in Danish and connecting with many key players in the field
The patch typically contains the active GLP-1 analogue within a reservoir or matrix system, alongside penetration enhancers that facilitate drug passage through the stratum corneum (the skin's outer protective layer)
Blood glucose was not altered in any of the groups, insulin decreased in all treatments, GLP-1 increased in groups with sitagliptin (alone or with acarbose) while GIP decreased in these same groups
With less SHBG circulating, more free testosterone becomes available to cause symptoms